Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

740
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
740
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

797
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
797
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.7K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.7K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

26
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 ESAIC Consensus Document on Mitigation Strategies in Intensive Care Medicine: Consensus document of the European Society of Anaesthesiology and Intensive Care.

European journal of anaesthesiology·2026
Same author

Post-cardiotomy ECMO configurations after mitral valve replacement: a case series and strategy development.

Perfusion·2026
Same author

A year in review in Minerva Anestesiologica 2025. Anesthesia, analgesia, and perioperative medicine.

Minerva anestesiologica·2026
Same author

Tracking pleural sliding motion to assess lung overdistention using an open source algorithm: a proof-of-concept study on lung ultrasound scans.

Critical care (London, England)·2026
Same author

Intensive Care management of Hemophagocytic Lymphohistiocytosis: a case series.

BMC anesthesiology·2025
Same author

Correction to: Gene expression kinetics in Sepsis After Cardiac Surgery (SACS): a multicentric prospective observational study.

Journal of anesthesia, analgesia and critical care·2025
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
Same journal

Multinational collaborations in critical care research: feasible and useful?

Current opinion in critical care·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K

Fluids in ARDS: from onset through recovery.

Luciano Gattinoni1, Massimo Cressoni, Luca Brazzi

  • 1aDipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan bDipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan cDipartimento di Scienze Chirurgiche, Microchirurgiche e Mediche, Università degli Studi di Sassari, Sassari dUnità Operativa Complessa di Anestesia e Rianimazione, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy.

Current Opinion in Critical Care
|July 1, 2014
PubMed
Summary
This summary is machine-generated.

Conservative fluid strategies improve oxygenation and reduce mechanical ventilation duration in acute respiratory distress syndrome (ARDS). Fluid overload must be avoided to improve patient outcomes and manage lung edema effectively.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

10.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

10.4K

Area of Science:

  • Critical Care Medicine
  • Pulmonary Medicine
  • Nephrology

Background:

  • Acute respiratory distress syndrome (ARDS) involves protein-rich lung edema and impaired fluid clearance.
  • Mechanical ventilation exacerbates fluid retention and hinders edema resolution pathways.

Purpose of the Study:

  • To review recent findings on fluid management strategies and edema clearance in ARDS.
  • To highlight the significance of lung edema in ARDS severity and outcomes.

Main Methods:

  • Review of current literature on fluid strategies and edema clearance in ARDS.
  • Discussion of monitoring techniques for fluid management.
  • Analysis of pharmacological interventions for edema clearance.

Main Results:

  • Conservative fluid strategies enhance oxygenation and shorten mechanical ventilation duration.
  • Echography aids in the safe administration of furosemide or hemofiltration.
  • Albumin and furosemide may accelerate edema clearance, especially with restored capillary permeability.
  • Beta-2 agonist therapy is not beneficial and potentially harmful for edema clearance.

Conclusions:

  • Lung edema is a critical factor in ARDS severity and prognosis; fluid overload must be prevented.
  • Various monitoring techniques support fluid management.
  • Current evidence does not support specific fluid compositions for ARDS; general sepsis guidelines may apply.